# Study of Radiotherapy Combined With Cisplatin/Carboplatin, Adebrelimab and Bevacizumab in the Treatment of TNBC-BM.

Source: https://onco.cc/trials/nct07638852/  
OnCo record `nct07638852` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of bevacizumab, cisplatin and carboplatin in triple-negative breast cancer, run by Fudan University, now recruiting.

## Summary

Study of Radiotherapy Combined With Cisplatin/Carboplatin, Adebrelimab and Bevacizumab in the Treatment of TNBC-BM. is a phase 2, randomised interventional study registered as NCT07638852 by Fudan University, with a registry enrolment figure of 58 participants, started 2026-02-02 and due to reach its primary completion in 2028-06-30. Interventions recorded: Radiation Therapy; Adebelimab; Bevacizumab; Cisplatin or carboplatin. Conditions listed: TNBC, Triple Negative Breast Cancer; Brain Metastasases. Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Also known as: ABC-R
- Tags: ctgov-ingest; tnbc-deep-dive
- Registry id: NCT07638852
- Phase: 2
- Setting: A Prospective, Two-arm, Multi-centre, Phase II Clinical Study of Radiotherapy Combined With Cisplatin/Carboplatin, Adebrelimab and Bevacizumab in the Treatment of Patients With Brain Metastasis From Triple-Negative Breast Cancer
- Sponsor: Fudan University
- Enrolled: 58

## Sources

- ClinicalTrials.gov NCT07638852: https://clinicaltrials.gov/study/NCT07638852

## Connected records

- cancers: [Early triple-negative breast cancer](https://onco.cc/cancers/tnbc-early/)
- terms: [Brain metastases (intracranial disease)](https://onco.cc/terms/brain-metastases/), [Triple-negative breast cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/tnbc-trials-open-today/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/), [Platinum agents](https://onco.cc/technologies/platinum/)
- drugs: [Bevacizumab](https://onco.cc/drugs/bevacizumab/), [Carboplatin](https://onco.cc/drugs/carboplatin/), [Cisplatin](https://onco.cc/drugs/cisplatin/)

---
JSON: https://onco.cc/api/v1/entities/nct07638852.json